190 related articles for article (PubMed ID: 15053240)
1. Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women.
Costante G; Crocetti U; Schifino E; Ludovico O; Capula C; Nicotera M; Arturi F; Filetti S
J Endocrinol Invest; 2004 Jan; 27(1):31-6. PubMed ID: 15053240
[TBL] [Abstract][Full Text] [Related]
2. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
[TBL] [Abstract][Full Text] [Related]
4. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules.
Papini E; Petrucci L; Guglielmi R; Panunzi C; Rinaldi R; Bacci V; Crescenzi A; Nardi F; Fabbrini R; Pacella CM
J Clin Endocrinol Metab; 1998 Mar; 83(3):780-3. PubMed ID: 9506726
[TBL] [Abstract][Full Text] [Related]
5. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial.
Bennedbaek FN; Nielsen LK; Hegedüs L
J Clin Endocrinol Metab; 1998 Mar; 83(3):830-5. PubMed ID: 9506736
[TBL] [Abstract][Full Text] [Related]
6. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.
Puzziello A; Carrano M; Angrisani E; Marotta V; Faggiano A; Zeppa P; Vitale M
J Endocrinol Invest; 2014 Dec; 37(12):1181-6. PubMed ID: 25008459
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of thyroid nodule growth.
Quadbeck B; Pruellage J; Roggenbuck U; Hirche H; Janssen OE; Mann K; Hoermann R
Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):348-54. PubMed ID: 12397534
[TBL] [Abstract][Full Text] [Related]
8. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
Appetecchia M
Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
[TBL] [Abstract][Full Text] [Related]
9. Changes in both size and cytological features of thyroid nodule after levothyroxine treatment.
Vermiglio F; Lo Presti VP; Violi MA; Moleti M; Castagna MG; Finocchiaro MD; Mattina F; Mandolfino M; Zimbaro G; Trimarchi F
Clin Endocrinol (Oxf); 2003 Sep; 59(3):347-53. PubMed ID: 12919158
[TBL] [Abstract][Full Text] [Related]
10. Levothyroxine suppressive therapy for solitary thyroid nodule.
Mainini E; Martinelli I; Morandi G; Villa S; Stefani I; Mazzi C
J Endocrinol Invest; 1995 Nov; 18(10):796-9. PubMed ID: 8787957
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of percutaneous ethanol injections in benign thyroid nodules.
Perez CL; Fighera TM; Miasaki F; Mesa Junior CO; Paz Filho GJ; Graf H; Carvalho GA
Arq Bras Endocrinol Metabol; 2014 Dec; 58(9):912-7. PubMed ID: 25627046
[TBL] [Abstract][Full Text] [Related]
12. Temporal Changes in Thyroid Nodule Volume: Lack of Effect on Paranodular Thyroid Tissue Volume.
Grani G; Bruno R; Lucisano G; Costante G; Meringolo D; Puxeddu E; Torlontano M; Tumino S; Attard M; Lamartina L; Nicolucci A; Cooper DS; Filetti S; Durante C
Thyroid; 2017 Nov; 27(11):1378-1384. PubMed ID: 28806880
[TBL] [Abstract][Full Text] [Related]
13. Effect of levothyroxine suppression therapy on plasma thrombin activatable fibrinolysis inhibitor antigen levels in benign thyroid nodules.
Akinci B; Demir T; Comlekci A; Yener S; Ozcan MA; Karaoglu O; Yuksel F; Secil M; Yesil S
Med Princ Pract; 2011; 20(1):23-8. PubMed ID: 21160209
[TBL] [Abstract][Full Text] [Related]
14. Suppressive therapy with levothyroxine for euthyroid diffuse and nodular goiter.
Güllü S; Gürses MA; Başkal N; Uysal AR; Kamel AN; Erdoğan G
Endocr J; 1999 Feb; 46(1):221-6. PubMed ID: 10426591
[TBL] [Abstract][Full Text] [Related]
15. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid.
La Rosa GL; Lupo L; Giuffrida D; Gullo D; Vigneri R; Belfiore A
Ann Intern Med; 1995 Jan; 122(1):1-8. PubMed ID: 7985890
[TBL] [Abstract][Full Text] [Related]
16. [Thyroxine therapy in benign thyroid nodules].
Vulpoi C; Zbranca E; Mogoş V; Preda C; Găleşanu C; Ungureanu MC; Ciobanu DG; Brănişteanu DD
Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):95-100. PubMed ID: 12092166
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal suppressive therapy of thyroid nodules].
Latapie JL; Leprat F; N'Guyen D; Catargi B; Latapie MJ
Ann Endocrinol (Paris); 1997; 58(6):459-62. PubMed ID: 9686004
[TBL] [Abstract][Full Text] [Related]
18. [Therapy with L-thyroxine in thyroid struma. Study with ultrasonic evaluation].
Peta M; Cartasegna S; Fabiani MP; Macchi R; Vecchi G; Costantino D
Recenti Prog Med; 1989 Jun; 80(6):320-5. PubMed ID: 2672195
[TBL] [Abstract][Full Text] [Related]
19. Is percutaneous ethanol injection a useful alternative for the treatment of the cold benign thyroid nodule? Five years' experience.
Caraccio N; Goletti O; Lippolis PV; Casolaro A; Cavina E; Miccoli P; Monzani F
Thyroid; 1997 Oct; 7(5):699-704. PubMed ID: 9349572
[TBL] [Abstract][Full Text] [Related]
20. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.
Wémeau JL; Caron P; Schvartz C; Schlienger JL; Orgiazzi J; Cousty C; Vlaeminck-Guillem V
J Clin Endocrinol Metab; 2002 Nov; 87(11):4928-34. PubMed ID: 12414852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]